Results from CAMELYON17: Using HALO AI to identify and stage breast cancer metastases

This application note describes how HALO AI™, from Indica Labs, was trained to automate identification and staging of metastases in breast cancer and how the final classifier performed in the CAMELYON17 Challenge. The results are highly encouraging for the transfer of this technology from research application to routine clinical use.